These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8883967)

  • 1. Prognostic significance of serum c-erbB-2 protein in breast cancer patients.
    Willsher PC; Beaver J; Pinder S; Bell JA; Ellis IO; Blamey RW; Robertson JF
    Breast Cancer Res Treat; 1996; 40(3):251-5. PubMed ID: 8883967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relevance of soluble c-erbB-2 for patients with metastatic breast cancer predicting the response to second-line hormone or chemotherapy.
    Classen S; Kopp R; Possinger K; Weidenhagen R; Eiermann W; Wilmanns W
    Tumour Biol; 2002; 23(2):70-5. PubMed ID: 12065844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-erbB-2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: prognostic value.
    Molina R; Jo J; Filella X; Zanon G; Pahisa J; Mu noz M; Farrus B; Latre ML; Escriche C; Estape J; Ballesta AM
    Breast Cancer Res Treat; 1998 Sep; 51(2):109-19. PubMed ID: 9879773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma c-erbB-2 levels in breast cancer patients: prognostic significance in predicting response to chemotherapy.
    Mehta RR; McDermott JH; Hieken TJ; Marler KC; Patel MK; Wild LD; Das Gupta TK
    J Clin Oncol; 1998 Jul; 16(7):2409-16. PubMed ID: 9667258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum c-erbB-2 protein in breast cancer patients.
    Chearskul S; Sinlarat P; Bhothisuwan K; Churintrapun M; Ornrhebroi S; Klinsala N; Sungkabunchoo S
    J Med Assoc Thai; 2000 Aug; 83(8):886-93. PubMed ID: 10998842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ELISA for quantitation of serum C-erbB-2 oncoprotein in breast cancer patients.
    Meenakshi A; Kumar RS; Kumar NS
    J Immunoassay Immunochem; 2002; 23(3):293-305. PubMed ID: 12227416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of serum and urinary c-erbB-2 levels in colorectal cancer.
    Tsigris C; Karayiannakis AJ; Zbar A; Syrigos KN; Baibas N; Diamantis T; Alexiou D
    Cancer Lett; 2002 Oct; 184(2):215-22. PubMed ID: 12127694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum c-erbB-2 protein is a useful marker for monitoring tumor recurrence of the breast.
    Imoto S; Wada N; Hasebe T; Ochiai A; Kitoh T
    Int J Cancer; 2007 Jan; 120(2):357-61. PubMed ID: 17044019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of c-erbB-2 serum protein in metastatic breast cancer.
    Fehm T; Maimonis P; Katalinic A; Jäger WH
    Oncology; 1998; 55(1):33-8. PubMed ID: 9428373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated soluble c-erbB-2 antigen levels in the serum and effusions of a proportion of breast cancer patients.
    Leitzel K; Teramoto Y; Sampson E; Mauceri J; Langton BC; Demers L; Podczaski E; Harvey H; Shambaugh S; Volas G
    J Clin Oncol; 1992 Sep; 10(9):1436-43. PubMed ID: 1355522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum c-erB-2 levels in monitoring of operable breast cancer patients.
    Imoto S; Kitoh T; Hasebe T
    Jpn J Clin Oncol; 1999 Jul; 29(7):336-9. PubMed ID: 10470658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of urokinase plasminogen activator receptor and c-erbB-2 in sera of patients with breast and ovarian carcinoma.
    Mabrouk RA; Ali-Labib R
    Clin Biochem; 2003 Oct; 36(7):537-43. PubMed ID: 14563447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MUC1 serum assays in breast cancer: tumor specificities and reference levels.
    Bjerner J; Norum LF; Nilsson O; Nustad K
    Tumour Biol; 2002; 23(6):315-23. PubMed ID: 12677089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum HER2/ECD value in stage I and II early breast cancer: need of a lower cut-off?
    Badzek S; Kelovic VL; Plestina S; Humar I; Veir Z; Mihaljevic Z
    Wien Klin Wochenschr; 2011 Dec; 123(23-24):726-31. PubMed ID: 22113445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-erbB-2 protein in the sera of breast cancer patients.
    Narita T; Funahashi H; Satoh Y; Takagi H
    Breast Cancer Res Treat; 1992; 24(2):97-102. PubMed ID: 8095169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients.
    Chen CH; Lin YS; Lin CC; Yang YH; Ho YP; Tsai CC
    J Oral Pathol Med; 2004 Nov; 33(10):589-94. PubMed ID: 15482324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of c-erbB-2 proteins in sera from patients with carcinomas and in breast tumor tissue cytosols: correlation with serum tumor markers and membrane-bound oncoprotein.
    Wu JT; Astill ME; Gagon SD; Bryson L
    J Clin Lab Anal; 1995; 9(3):151-65. PubMed ID: 7541455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of C-erbB-2 (HER-2/neu) in patients with malignant and non-malignant diseases.
    Molina R; Jo J; Filella X; Bruix J; Castells A; Hague M; Ballesta AM
    Tumour Biol; 1997; 18(3):188-96. PubMed ID: 9143415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential use of saliva to detect recurrence of disease in women with breast carcinoma.
    Bigler LR; Streckfus CF; Copeland L; Burns R; Dai X; Kuhn M; Martin P; Bigler SA
    J Oral Pathol Med; 2002 Aug; 31(7):421-31. PubMed ID: 12165061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of c-erbB-2 related protein in sera from breast cancer patients. Relationship to ERBB2 gene amplification and c-erbB-2 protein overexpression in tumour.
    Andersen TI; Paus E; Nesland JM; McKenzie SJ; Børresen AL
    Acta Oncol; 1995; 34(4):499-504. PubMed ID: 7605658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.